Next Article in Journal
Cohen Syndrome Patient iPSC-Derived Neurospheres and Forebrain-Like Glutamatergic Neurons Reveal Reduced Proliferation of Neural Progenitor Cells and Altered Expression of Synapse Genes
Next Article in Special Issue
Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US
Previous Article in Journal
Complex Oncological Decision-Making Utilizing Fast-and-Frugal Trees in a Community Setting—Role of Academic and Hybrid Modeling
Previous Article in Special Issue
COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge
Review

Vaccines and Therapies in Development for SARS-CoV-2 Infections

1
Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL 60612, USA
2
National Institute of Virology, Indian Council of Medical Research, Mumbai 400012, India
3
Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2020, 9(6), 1885; https://doi.org/10.3390/jcm9061885
Received: 10 May 2020 / Revised: 4 June 2020 / Accepted: 8 June 2020 / Published: 16 June 2020
The current COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. The virus causes severe respiratory symptoms which manifest disproportionately in the elderly. Currently, there are over 6.5 million cases and 380,000 deaths reported. Given the current severity of the outbreak, there is a great need for antiviral therapies and vaccines to treat and prevent COVID-19. In this review, we provide an overview of SARS-CoV-2 and discuss the emerging therapies and vaccines that show promise in combating COVID-19. We also highlight potential viral targets that could be exploited by researchers and drug manufacturers. View Full-Text
Keywords: SARS-CoV-2; therapies; vaccines; COVID-19; coronavirus SARS-CoV-2; therapies; vaccines; COVID-19; coronavirus
Show Figures

Figure 1

MDPI and ACS Style

Wu, D.; Koganti, R.; Lambe, U.P.; Yadavalli, T.; Nandi, S.S.; Shukla, D. Vaccines and Therapies in Development for SARS-CoV-2 Infections. J. Clin. Med. 2020, 9, 1885. https://doi.org/10.3390/jcm9061885

AMA Style

Wu D, Koganti R, Lambe UP, Yadavalli T, Nandi SS, Shukla D. Vaccines and Therapies in Development for SARS-CoV-2 Infections. Journal of Clinical Medicine. 2020; 9(6):1885. https://doi.org/10.3390/jcm9061885

Chicago/Turabian Style

Wu, David, Raghuram Koganti, Upendra P. Lambe, Tejabhiram Yadavalli, Shyam S. Nandi, and Deepak Shukla. 2020. "Vaccines and Therapies in Development for SARS-CoV-2 Infections" Journal of Clinical Medicine 9, no. 6: 1885. https://doi.org/10.3390/jcm9061885

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop